Key result
Anticoagulant therapy, including heparins, vitamin K antagonists, and novel oral anticoagulants, plays a crucial role in the prevention and treatment of thrombosis and embolization across various systemic diseases.
This narrative review summarizes the pharmacology, clinical indications, and adverse effects of various anticoagulant therapies used to prevent and treat embolization across multiple cardiovascular conditions.
Answers are grounded in this paper and cite their sources.
Affirms anticoagulants' established role in thrombosis prevention; leaves open optimal agent selection across systemic diseases.
Objective: To provide a comprehensive review on anticoagulant therapy and other treatment options to prevent embolisation. Background: An embolism is the lodging of an embolus, which may be a blood clot, fat globule, air bubble or foreign material in the bloodstream, resulting in a blockage of the blood flow to a paricular organ. Based on the organ affected, it is classified as pulmonary embolism, brain embolism, retinal embolism etc. Anticoagulants are a group of drugs that reduces the body's ability to form clots in the blood and thus they play a great role in both the prevention and treatment of established embolism.
No takes yet. Share an insight, caveat, or question.
Umme Salma Durbar (2016) conducted a review in Embolization and Thrombosis. Anticoagulant therapy was evaluated. Anticoagulant therapy, including heparins, vitamin K antagonists, and novel oral anticoagulants, plays a crucial role in the prevention and treatment of thrombosis and embolization across various systemic diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: